Cardior Pharmaceuticals
Cardior Pharmaceuticals discovers and develops medicines and therapeutics for the treatment and prevention of heart disease.
2
Funding Rounds
$91.7m
Money raised
Overview
Cardior Pharmaceuticals discovers and develops medicines and therapeutics for the treatment and prevention of heart disease.
-
Website:
- Headquarters: Hanover
- Social accounts:
Funding
Funding series
Funding Series Analysis
The company Cardior Pharmaceuticals has raised a total of $91.7m in funding over 2 rounds.
Key Insights:
- Cardior Pharmaceuticals Series B round, August 2021: $75.3m
- Cardior Pharmaceuticals Series A round, May 2017: $16.4m
Cardior Pharmaceuticals Series B round, August 2021
$75.3m
Cardior Pharmaceuticals Series A round, May 2017
$16.4m
Industries
Cardior Pharmaceuticals is active in the following industries: